Designed for advanced OB-GYN applications, the Samsung Z20 ultrasound platform reportedly provides a combination of artificial intelligence (AI) tools and enhanced ergonomics.
Offering a variety of artificial intelligence (AI) features to bolster workflow efficiency, Samsung plans to launch the Z20 ultrasound system at the Society for Maternal-Fetal Medicine conference (continuing today through February 1) in Denver.
Samsung noted the Z20 ultrasound’s deep learning feature Live ViewAssist™ provides automated labeling of up to 47 anatomic structures, performs 46 key measurements and facilitates up to a 94 reduction in keystrokes.
The Z20 ultrasound system, which will be launched at he upcoming Maternal-Fetal Medicine conference in Denver, reportedly performs 46 key measurements and provides automatic labeling of 47 anatomic structures for OB-GYN exams, according to Samsung, the developer of the Z20 ultrasound system. (Photo courtesy of Samsung.)
Employing advanced software beamforming, the Z20 ultrasound system offers enhanced diagnostic accuracy, even in cases involving patients with a high body mass index (BMI), according to Samsung. The company added that recent independent testing of the Z20 device found that it met or exceeded all standard ergonomic measurements.
“The Z20 represents a significant technology milestone for both Samsung and the broader ultrasound industry. … (It) also reflects our commitment to breaking the iron triangle of healthcare cost, access, and quality by integrating the Z20 with a digital ecosystem for telesonography, reporting, and fleet management,” noted Tracy Bury, the vice president and head of ultrasound USA and global growth initiatives at Samsung Medison.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.